BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 991 filers reported holding BAXTER INTL INC in Q3 2022. The put-call ratio across all filers is 1.55 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,185,036 | -16.9% | 31,400 | +0.3% | 0.03% | -15.6% |
| Q2 2023 | $1,426,028 | +7.2% | 31,300 | -4.6% | 0.03% | -5.9% |
| Q1 2023 | $1,330,368 | +79946.2% | 32,800 | +0.6% | 0.03% | -26.1% |
| Q4 2022 | $1,662 | -99.9% | 32,600 | +1.2% | 0.05% | -9.8% |
| Q3 2022 | $1,734,000 | -16.8% | 32,200 | +0.9% | 0.05% | -8.9% |
| Q2 2022 | $2,084,000 | -16.0% | 31,900 | +0.9% | 0.06% | -5.1% |
| Q1 2022 | $2,482,000 | -7.9% | 31,600 | +0.6% | 0.06% | 0.0% |
| Q4 2021 | $2,695,000 | +7.8% | 31,400 | +1.0% | 0.06% | -1.7% |
| Q3 2021 | $2,501,000 | -0.8% | 31,100 | -0.6% | 0.06% | -1.6% |
| Q2 2021 | $2,520,000 | -4.5% | 31,300 | 0.0% | 0.06% | -11.6% |
| Q1 2021 | $2,640,000 | +3.8% | 31,300 | -1.3% | 0.07% | -6.8% |
| Q4 2020 | $2,544,000 | +23.1% | 31,700 | +23.3% | 0.07% | -22.1% |
| Q3 2020 | $2,067,000 | +9.6% | 25,700 | +17.4% | 0.10% | -15.2% |
| Q2 2020 | $1,886,000 | +7.0% | 21,900 | +0.9% | 0.11% | -12.5% |
| Q1 2020 | $1,762,000 | -12.9% | 21,700 | -10.3% | 0.13% | +28.0% |
| Q4 2019 | $2,024,000 | -5.9% | 24,200 | -1.6% | 0.10% | -11.5% |
| Q3 2019 | $2,152,000 | +10.8% | 24,600 | +3.4% | 0.11% | +15.3% |
| Q2 2019 | $1,943,000 | -5.2% | 23,800 | -5.6% | 0.10% | -3.9% |
| Q1 2019 | $2,049,000 | +19.8% | 25,200 | -3.1% | 0.10% | +5.2% |
| Q4 2018 | $1,711,000 | -23.7% | 26,000 | -10.7% | 0.10% | +1.0% |
| Q3 2018 | $2,243,000 | +4.8% | 29,100 | +0.3% | 0.10% | 0.0% |
| Q2 2018 | $2,141,000 | +8.6% | 29,000 | -4.3% | 0.10% | +6.7% |
| Q1 2018 | $1,971,000 | +0.6% | 30,300 | 0.0% | 0.09% | +1.1% |
| Q4 2017 | $1,959,000 | -0.3% | 30,300 | -3.2% | 0.09% | -3.3% |
| Q3 2017 | $1,964,000 | +7.1% | 31,300 | +3.3% | 0.09% | +2.2% |
| Q2 2017 | $1,834,000 | +18.2% | 30,300 | +1.3% | 0.09% | +15.4% |
| Q1 2017 | $1,551,000 | +13.5% | 29,900 | -2.9% | 0.08% | +11.4% |
| Q4 2016 | $1,366,000 | -8.0% | 30,800 | -1.3% | 0.07% | -10.3% |
| Q3 2016 | $1,485,000 | -9.3% | 31,200 | -13.8% | 0.08% | -9.3% |
| Q2 2016 | $1,637,000 | +8.8% | 36,200 | -1.1% | 0.09% | +10.3% |
| Q1 2016 | $1,504,000 | +2.9% | 36,600 | -4.4% | 0.08% | +5.4% |
| Q4 2015 | $1,461,000 | +11.8% | 38,300 | -3.8% | 0.07% | +8.8% |
| Q3 2015 | $1,307,000 | -52.9% | 39,800 | +0.3% | 0.07% | -48.5% |
| Q2 2015 | $2,776,000 | +3.7% | 39,700 | +1.5% | 0.13% | +3.1% |
| Q1 2015 | $2,678,000 | -10.4% | 39,100 | -4.2% | 0.13% | -6.6% |
| Q4 2014 | $2,990,000 | +0.1% | 40,800 | -1.9% | 0.14% | -4.2% |
| Q3 2014 | $2,986,000 | -3.1% | 41,600 | -2.3% | 0.14% | 0.0% |
| Q2 2014 | $3,080,000 | -2.9% | 42,600 | -1.2% | 0.14% | -5.3% |
| Q1 2014 | $3,171,000 | +4.3% | 43,100 | -1.4% | 0.15% | +4.9% |
| Q4 2013 | $3,039,000 | – | 43,700 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |